932.85 40.35 (4.52%)

68.08% Gain from 52W Low

192.2K NSE+BSE Volume

NSE 16 Jul, 2025 3:31 PM (IST)

US FDA Classification
Shilpa Medicare's Bengaluru facility gets US FDA's voluntary action indicated (VAI) classification See details


Shilpa Medicare Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SHILPAMED, BSE:530549 Shilpa Medicare Ltd.

246 Votes:
Buy 78.86%
Sell 11.79%
Hold 9.35%
BUY
SELL
HOLD